Costs of illness and care in Parkinson's Disease: An evaluation in six countries

Sonja von Campenhausen, Yaroslav Winter, Antonio Rodrigues e Silva, Christina Sampaio, Evzen Ruzicka, Paolo Barone, Werner Poewe, Alla Guekht, Céu Mateus, Karl P. Pfeiffer, Karin Berger, Jana Skoupa, Kai Bötzel, Sabine Geiger-Gritsch, Uwe Siebert, Monika Balzer-Geldsetzer, Wolfgang H. Oertel, Richard Dodel, Jens P. Reese

Research output: Contribution to journalArticlepeer-review

74 Citations (Scopus)
389 Downloads (Pure)


We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.

Original languageEnglish
Pages (from-to)180-191
Number of pages12
JournalEuropean Neuropsychopharmacology
Issue number2
Publication statusPublished - 1 Feb 2011


  • Care
  • Cost
  • Cost-of-illness
  • Economic burden
  • Europe
  • Parkinson's Disease


Dive into the research topics of 'Costs of illness and care in Parkinson's Disease: An evaluation in six countries'. Together they form a unique fingerprint.

Cite this